Logo image of GLIBA

GCI LIBERTY INC-CL A (GLIBA) Stock Fundamental Analysis

USA - NASDAQ:GLIBA - US36164V6020 - Common Stock

36.08 USD
-0.86 (-2.33%)
Last: 10/10/2025, 9:31:42 PM
Fundamental Rating

2

GLIBA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 36 industry peers in the Diversified Telecommunication Services industry. GLIBA has a bad profitability rating. Also its financial health evaluation is rather negative. GLIBA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year GLIBA was profitable.
GLIBA Yearly Net Income VS EBIT VS OCF VS FCFGLIBA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.09%, GLIBA is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
GLIBA has a Return On Equity (4.74%) which is in line with its industry peers.
GLIBA has a Return On Invested Capital (3.00%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 2.09%
ROE 4.74%
ROIC 3%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GLIBA Yearly ROA, ROE, ROICGLIBA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 1 2 3 4

1.3 Margins

GLIBA has a Profit Margin of 6.89%. This is in the better half of the industry: GLIBA outperforms 66.67% of its industry peers.
With a decent Operating Margin value of 13.78%, GLIBA is doing good in the industry, outperforming 61.11% of the companies in the same industry.
GLIBA's Gross Margin of 53.64% is in line compared to the rest of the industry. GLIBA outperforms 55.56% of its industry peers.
Industry RankSector Rank
OM 13.78%
PM (TTM) 6.89%
GM 53.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GLIBA Yearly Profit, Operating, Gross MarginsGLIBA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 10 20 30 40 50

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GLIBA is destroying value.
GLIBA has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for GLIBA is higher compared to a year ago.
GLIBA Yearly Shares OutstandingGLIBA Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 5M 10M 15M 20M 25M
GLIBA Yearly Total Debt VS Total AssetsGLIBA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 1B 2B 3B

2.2 Solvency

GLIBA has an Altman-Z score of 0.68. This is a bad value and indicates that GLIBA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.68, GLIBA is doing worse than 63.89% of the companies in the same industry.
GLIBA has a Debt/Equity ratio of 0.71. This is a neutral value indicating GLIBA is somewhat dependend on debt financing.
The Debt to Equity ratio of GLIBA (0.71) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z 0.68
ROIC/WACC0.5
WACC6.02%
GLIBA Yearly LT Debt VS Equity VS FCFGLIBA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 500M 1B

2.3 Liquidity

GLIBA has a Current Ratio of 1.42. This is a normal value and indicates that GLIBA is financially healthy and should not expect problems in meeting its short term obligations.
GLIBA has a better Current ratio (1.42) than 75.00% of its industry peers.
A Quick Ratio of 1.42 indicates that GLIBA should not have too much problems paying its short term obligations.
GLIBA's Quick ratio of 1.42 is fine compared to the rest of the industry. GLIBA outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
GLIBA Yearly Current Assets VS Current LiabilitesGLIBA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

GLIBA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.73%, which is quite impressive.
Looking at the last year, GLIBA shows a small growth in Revenue. The Revenue has grown by 3.57% in the last year.
EPS 1Y (TTM)70.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)3.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GLIBA Yearly Revenue VS EstimatesGLIBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 200M 400M 600M 800M 1B

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.79, which indicates a correct valuation of GLIBA.
Based on the Price/Earnings ratio, GLIBA is valued a bit cheaper than 75.00% of the companies in the same industry.
GLIBA is valuated rather cheaply when we compare the Price/Earnings ratio to 27.02, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.79
Fwd PE N/A
GLIBA Price Earnings VS Forward Price EarningsGLIBA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GLIBA is valued cheaper than 88.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.8
GLIBA Per share dataGLIBA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GLIBA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GCI LIBERTY INC-CL A

NASDAQ:GLIBA (10/10/2025, 9:31:42 PM)

36.08

-0.86 (-2.33%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners31.89%
Inst Owner ChangeN/A
Ins Owners9.11%
Ins Owner Change-0.24%
Market Cap1.04B
Analysts100
Price TargetN/A
Short Float %4.3%
Short Ratio2.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.79
Fwd PE N/A
P/S 1.02
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB N/A
EV/EBITDA 5.8
EPS(TTM)2.44
EY6.76%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS35.4
BVpS51.46
TBVpS-8.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.09%
ROE 4.74%
ROCE 4.43%
ROIC 3%
ROICexc 3.1%
ROICexgc 7.13%
OM 13.78%
PM (TTM) 6.89%
GM 53.64%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA 3.03
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z 0.68
F-ScoreN/A
WACC6.02%
ROIC/WACC0.5
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.72%
OCF growth 3YN/A
OCF growth 5YN/A